CHAMPIONS ONCOLOGY, INC. — All Filings
646 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10QSB/A
3
3/A
4
4/A
424B3
424B4
5
8-A12B
8-K
8-K/A
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
DEFA14A
DEFC14A
DEFM14A
DEFR14A
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRE 14C
PRER14A
PRER14C
S-1
S-1/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001628280-26-017345 | Mar 12, 2026 | Jan 31, 2026 |
| 8-K | 8-K | 0001628280-26-017259 | Mar 12, 2026 | — |
| 4 | FORM 4 | 0001628280-26-004381 | Jan 30, 2026 | Jul 16, 2025 |
| 4 | FORM 4 | 0001628280-26-004342 | Jan 30, 2026 | Nov 5, 2021 |
| 3 | FORM 3 | 0001628280-26-002423 | Jan 16, 2026 | Jun 9, 2021 |
| 10-Q | 10-Q | 0001628280-25-057082 | Dec 15, 2025 | Oct 31, 2025 |
| 8-K | 8-K | 0001628280-25-057020 | Dec 15, 2025 | — |
| 4 | FORM 4 | 0001628280-25-050522 | Nov 7, 2025 | Nov 5, 2025 |
| 4 | FORM 4 | 0001628280-25-050514 | Nov 7, 2025 | Nov 5, 2025 |
| 4 | FORM 4 | 0001628280-25-050491 | Nov 7, 2025 | Nov 5, 2025 |
| 4 | FORM 4 | 0001628280-25-050481 | Nov 7, 2025 | Nov 5, 2025 |
| 4 | FORM 4 | 0001628280-25-050467 | Nov 7, 2025 | Nov 5, 2025 |
| 4 | FORM 4 | 0001628280-25-049954 | Nov 6, 2025 | Oct 30, 2025 |
| 8-K | 8-K | 0001628280-25-045241 | Oct 16, 2025 | — |
| 10-Q | 10-Q | 0000771856-25-000023 | Sep 15, 2025 | Jul 31, 2025 |
| 8-K | 8-K | 0000771856-25-000022 | Sep 15, 2025 | — |
| DEFA14A | DEFA14A | 0000771856-25-000010 | Aug 22, 2025 | — |
| DEF 14A | DEF 14A | 0000771856-25-000009 | Aug 22, 2025 | — |
| 10-K | 10-K | 0001628280-25-035765 | Jul 23, 2025 | Apr 30, 2025 |
| 8-K | 8-K | 0001628280-25-035727 | Jul 23, 2025 | — |
| 8-K | 8-K | 0001628280-25-035424 | Jul 21, 2025 | — |
| 4 | FORM 4 | 0001628280-25-016197 | Apr 2, 2025 | Mar 25, 2025 |
| 10-Q | 10-Q | 0001628280-25-012941 | Mar 17, 2025 | Jan 31, 2025 |
| 8-K | 8-K | 0001628280-25-012022 | Mar 11, 2025 | — |
| UPLOAD | — | 0000000000-25-002410 | Mar 4, 2025 | — |
| CORRESP | — | 0001628280-25-009486 | Mar 3, 2025 | — |
| UPLOAD | — | 0000000000-25-002216 | Feb 26, 2025 | — |
| SCHEDULE 13G/A | — | 0000919574-25-001459 | Feb 14, 2025 | — |
| 10-Q | 10-Q | 0001628280-24-051389 | Dec 16, 2024 | Oct 31, 2024 |
| 8-K | 8-K | 0001628280-24-050789 | Dec 11, 2024 | — |
| 4 | FORM 4 | 0001628280-24-048217 | Nov 18, 2024 | Nov 12, 2024 |
| 4 | FORM 4 | 0001628280-24-048211 | Nov 18, 2024 | Nov 12, 2024 |
| 4 | FORM 4 | 0001628280-24-048205 | Nov 18, 2024 | Nov 12, 2024 |
| 4 | FORM 4 | 0001628280-24-048196 | Nov 18, 2024 | Nov 12, 2024 |
| 4 | FORM 4 | 0001628280-24-048193 | Nov 18, 2024 | Nov 12, 2024 |
| SC 13G/A | — | 0001398344-24-020764 | Nov 14, 2024 | — |
| 4 | FORM 4 | 0001628280-24-044663 | Nov 1, 2024 | Oct 31, 2024 |
| S-8 | S-8 | 0001628280-24-044300 | Oct 30, 2024 | — |
| 8-K | 8-K | 0001628280-24-042780 | Oct 15, 2024 | Oct 14, 2024 |
| 8-K | 8-K | 0001628280-24-042039 | Oct 3, 2024 | — |
| 10-Q | 10-Q | 0001628280-24-040312 | Sep 13, 2024 | Jul 31, 2024 |
| 8-K | 8-K | 0001628280-24-040137 | Sep 11, 2024 | — |
| DEFA14A | DEFA14A | 0001628280-24-038543 | Aug 27, 2024 | — |
| DEF 14A | DEF 14A | 0001628280-24-038540 | Aug 27, 2024 | — |
| 10-K | 10-K | 0001628280-24-032321 | Jul 19, 2024 | Apr 30, 2024 |
| 8-K | 8-K | 0001628280-24-032227 | Jul 18, 2024 | — |
| SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. -- CHAMPIONS ONCOLOGY 13D/A(#1) | 0001072613-24-000427 | May 6, 2024 | — |
| 4 | FORM 4 | 0001628280-24-013993 | Apr 1, 2024 | Oct 9, 2023 |
| 10-Q | 10-Q | 0001628280-24-011279 | Mar 15, 2024 | Jan 31, 2024 |
| 8-K | 8-K | 0001628280-24-010569 | Mar 12, 2024 | — |